During this session on January 27, 2010, we focused on Corporate Governance Developments.
The Corporate Governance Developments panel addressed recent regulatory and legislative developments in corporate governance, other than issues related directly to executive compensation. The program also provided practical insights and guidance for boards of directors in understanding and dealing with the changing corporate governance landscape.
This session was moderated by Foley Partner Peter C. Underwood, and included panelists Robert Allgyer, Executive Director, Mergers & Acquisitions, UBS Investment Bank; John Gimpert, Partner, Deloitte & Touche LLP; and Neil Matthews, Partner, Eversheds LLP.
Related Insights
July 16, 2025
Health Care Law Today Podcast
Episode 36: Let’s Talk Compliance: The Risks and Pitfalls of Health Care Supply Chain Compliance
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…